Surface Modification Strategies for Chrysin-Loaded Iron Oxide Nanoparticles to Boost Their Anti-Tumor Efficacy in Human Colon Carcinoma Cells
Source abstract
Abstract
Enhancing nanoparticles’ anti-cancer capabilities as drug carriers requires the careful adjustment of formulation parameters, including loading efficiency, drug/carrier ratio, and synthesis method. Small adjustments to these parameters can significantly influence the drug-loading efficiency of nanoparticles. Our study explored how chitosan and polyethylene glycol (PEG) coatings affect the structural properties, drug-loading efficiency, and anti-cancer efficacy of Fe3O4 nanoparticles (NPs). The loading efficiency of the NPs was determined using FTIR spectrometry and XRD. The quantity of chrysin incorporated into the coated NPs was examined using UV–Vis spectrometry. The effect of the NPs on cell viability and apoptosis was determined by employing the HCT 116 human colon carcinoma cell line. We showed that a two-fold increase in drug concentration did not impact the loading efficiency of Fe3O4 NPs coated with PEG. However, there was a 33 Å difference in the crystallite sizes obtained from chitosan-coated Fe3O4 NPs and drug concentrations of 1:0.5 and 1:2, resulting in decreased system stability. In conclusion, PEG coating exhibited a higher loading efficiency of Fe3O4 NPs compared to chitosan, resulting in enhanced anti-tumor effects. Furthermore, variations in the loaded amount of chrysin did not impact the crystallinity of PEG-coated NPs, emphasizing the stability and regularity of the system.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Nanoresearch Laboratory, Baku State University, Baku AZ 1148, Azerbaijan
Department of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany
Laboratori Nazionali di Frascati, Istituto Nazionale di Fisica Nucleare, 00044 Frascati, Italy
References (62)
Show source-provided references
1. Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., and Shao, A. (2020). Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci., 7.10.3389/fmolb.2020.00193 ↗
2. Yagublu, V., Karimova, A., Hajibabazadeh, J., Reissfelder, C., Muradov, M., Bellucci, S., and Allahverdiyev, A. (2022). Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy. J. Funct. Biomater., 13.10.3390/jfb13040196 ↗
3. Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy10.1016/j.pmatsci.2019.100599 ↗
4. Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies10.1021/acs.chemrev.5b00589 ↗
5. Magnetism for drug delivery, MRI and hyperthermia applications: A review
6. Włodarczyk, A., Gorgoń, S., Radoń, A., and Bajdak-Rusinek, K. (2022). Magnetite nanoparticles in magnetic hyperthermia and cancer therapies: Challenges and perspectives. Nanomaterials, 12.10.3390/nano12111807 ↗
7. Nanomedicine-based commercial formulations: Current developments and future prospects10.1007/s40005-022-00607-6 ↗
8. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: In vivo studies10.1016/j.jconrel.2009.09.013 ↗
9. Magnetic nanoparticles for precision oncology: Theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy10.2217/nnm-2016-0316 ↗
10. Organ-specific toxicity of magnetic iron oxide-based nanoparticles10.1080/17435390.2020.1842934 ↗
11. Malhotra, N., Lee, J.-S., Liman, R.A.D., Ruallo, J.M.S., Villaflores, O.B., Ger, T.-R., and Hsiao, C.-D. (2020). Potential toxicity of iron oxide magnetic nanoparticles: A review. Molecules, 25.10.3390/molecules25143159 ↗
12. Magnetic biohybrid microrobot multimers based on chlorella cells for enhanced targeted drug delivery10.1021/acsami.1c16859 ↗
13. Overcoming in vivo barriers to targeted nanodelivery10.1002/wnan.143 ↗
14. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: A review10.1007/s11051-023-05690-w ↗
15. Effect of PEG molecular weight on stability, T2 contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs)10.1016/j.colsurfb.2014.04.027 ↗
16. PEGylation of superparamagnetic iron oxide nanoparticle for drug delivery applications with decreased toxicity: An in vivo study10.1007/s11051-015-3216-x ↗
17. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications10.1016/j.addr.2019.01.005 ↗
18. Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications10.3390/ijms140714550 ↗
19. Friedrich, B., Auger, J.-P., Dutz, S., Cicha, I., Schreiber, E., Band, J., Boccacccini, A.R., Krönke, G., Alexiou, C., and Tietze, R. (2021). Hydroxyapatite-coated SPIONs and their influence on cytokine release. Int. J. Mol. Sci., 22.10.3390/ijms22084143 ↗
20. Tóth, I.Y., Illés, E., Szekeres, M., Zupkó, I., Turcu, R., and Tombácz, E. (2019). Chondroitin-Sulfate-A-Coated Magnetite Nanoparticles: Synthesis, Characterization and Testing to Predict Their Colloidal Behavior in Biological Milieu. Int. J. Mol. Sci., 20.10.3390/ijms20174096 ↗
21. Polyacrylic acid-coated iron oxide nanoparticles could be a useful tool for tracking inflammatory monocytes10.2144/fsoa-2019-0066 ↗
22. Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms10.2174/0929867325666180601101859 ↗
23. Maghemite nanoparticles protectively coated with poly (ethylene imine) and poly (ethylene oxide)-block-poly (glutamic acid)10.1021/la052990d ↗
24. Magnetic nanoparticles for gene and drug delivery
25. Nathanael, A.J., and Oh, T.H. (2020). Biopolymer coatings for biomedical applications. Polymers, 12.10.3390/polym12123061 ↗
26. Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release10.1039/c1jm10631g ↗
27. Drug delivery and targeting
28. Loading and release mechanism of red clover necrotic mosaic virus derived plant viral nanoparticles for drug delivery of doxorubicin10.1002/smll.201400558 ↗
29. nanoparticles: Synthesis, surface functional strategies and biomedical applications Recent progress on magnetic iron oxide nanoparticles: Synthesis, surface functional strategies and biomedical applications10.1088/1468-6996/16/2/023501 ↗
30. Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery10.1016/j.biomaterials.2011.08.053 ↗
31. Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin10.1186/s12935-021-01906-y ↗
32. Synthesis and characterization of magnetite nanoparticles via the chemical co-precipitation method10.1016/j.mseb.2012.01.003 ↗
33. Nanoparticle-based targeted drug delivery10.1016/j.yexmp.2008.12.004 ↗
34. Kinetics of cisplatin release by in-vitro using poly (D, L-Lactide) coated Fe3O4 Nanocarriers10.1109/TNB.2012.2230024 ↗
35. Wallyn, J., Anton, N., and Vandamme, T.F. (2019). Synthesis, principles, and properties of magnetite nanoparticles for in vivo imaging applications—A review. Pharmaceutics, 11.10.3390/pharmaceutics11110601 ↗
36. Green synthesis of iron oxide nanoparticles. Development of magnetic hybrid materials for efficient As (V) removal10.1016/j.cej.2016.04.149 ↗
37. A synthesis of polyethylene glycol (PEG)-coated magnetite Fe3O4 nanoparticles and their characteristics for enhancement of biosensor10.1088/2053-1591/ab8bef ↗
38. Synthesis and characterization of chrysin-loaded β-cyclodextrin-based nanosponges to enhance in-vitro solubility, photostability, drug release, antioxidant effects and antitumorous efficacy10.1166/jnn.2017.13911 ↗
39. Primaquine loaded chitosan nanoparticles for liver targeting10.2174/2211738511301010035 ↗
40. Chrysin cocrystals: Characterization and evaluation10.1016/j.jpba.2016.10.020 ↗
41. Saptarshi, S.R., Duschl, A., and Lopata, A.L. (2013). Interaction of nanoparticles with proteins: Relation to bio-reactivity of the nanoparticle. J. Nanobiotechnology, 11.10.1186/1477-3155-11-26 ↗
42. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles10.1002/anie.200700465 ↗
43. Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery
44. Siafaka, P.I., Üstündağ Okur, N., Karavas, E., and Bikiaris, D.N. (2016). Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: Current status and uses. Int. J. Mol. Sci., 17.10.3390/ijms17091440 ↗
45. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery10.1016/j.msec.2019.109950 ↗
46. Surface-coated magnetic nanostructured materials for robust bio-catalysis and biomedical applications-A review10.1016/j.jare.2021.09.013 ↗
47. Yusuf, A., Almotairy, A.R.Z., Henidi, H., Alshehri, O.Y., and Aldughaim, M.S. (2023). Nanoparticles as Drug Delivery Systems: A Review of the implication of nanoparticles’ physicochemical properties on responses in biological systems. Polymers, 15.10.3390/polym15071596 ↗
48. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly (2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes10.1021/acsnano.8b01806 ↗
49. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes10.1038/srep26269 ↗
50. Biocompatibility and anticancer activity of L-phenyl alanine-coated iron oxide magnetic nanoparticles as potential chrysin delivery system10.1557/jmr.2018.148 ↗
51. Encapsulation of Doxorubicin and Chrysin on magnetic PCLPEG-PCL nanoparticles: Optimization of parameters and drug delivery evaluation
52. Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications10.1016/j.ijpharm.2014.03.016 ↗
53. The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles10.1016/j.matchemphys.2015.04.022 ↗
54. Reyes-Ortega, F., Delgado, Á.V., Schneider, E.K., Checa Fernández, B., and Iglesias, G. (2017). Magnetic nanoparticles coated with a thermosensitive polymer with hyperthermia properties. Polymers, 10.10.3390/polym10010010 ↗
55. PEG size effect and its interaction with Fe3O4 nanoparticles synthesized by solvothermal method: Morphology and effect of pH on the stability10.1088/2632-959X/ac0596 ↗
56. A novel facile synthesis of metal nitride@ metal oxide (BN/Gd2O3) nanocomposite and their antibacterial and anticancer activities10.1038/s41598-023-49895-4 ↗
57. Perceptive review on properties of iron oxide nanoparticles and their antimicrobial and anticancer activity
58. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
59. Polystyrene-poly (ethylene glycol)(PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution10.1023/A:1018939521589 ↗
60. Uthaman, S., Lee, S.J., Cherukula, K., Cho, C.-S., and Park, I.-K. (2015). Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy. BioMed Res. Int., 2015.10.1155/2015/959175 ↗
61. Application of polysaccharides for surface modification of nanomedicines10.4155/tde.12.105 ↗
62. Aibani, N., Rai, R., Patel, P., Cuddihy, G., and Wasan, E.K. (2021). Chitosan nanoparticles at the biological interface: Implications for drug delivery. Pharmaceutics, 13.10.3390/pharmaceutics13101686 ↗